Ovarian steroids counteract serotonergic drugs actions in an animal model of obsessive-compulsive disorder

Psychoneuroendocrinology

Volumn 31, Issue 8, 2006, Pages 924-934

  Fernández Guasti, Alonso ^a   Agrati, Daniella ^b   Reyes, Rebeca ^a   Ferreira, Annabel ^b  

^a Cinvestav Coapa   (Mexico)

^b FACULTAD DE CIENCIAS   (Uruguay)

Author keywords

8 OH DPAT; Estrous cycle; Fluoxetine; Obsessive compulsive disorder; Ovarian steroids; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ESTROGEN; FLUOXETINE; PROGESTERONE; SEROTONIN 1 AGONIST; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN ACTIVITY; ESTROGEN SYNTHESIS; ESTRUS; FEMALE; HORMONAL REGULATION; MAZE TEST; METESTRUS; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; OVARIECTOMY; OVARY CYCLE; PERSEVERATION; PRIORITY JOURNAL; PROGESTERONE SYNTHESIS; RAT; SEROTONINERGIC SYSTEM;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ESTRADIOL; ESTROUS CYCLE; FEMALE; FLUOXETINE; OBSESSIVE-COMPULSIVE DISORDER; OVARIECTOMY; OVARY; PROGESTERONE; RATS; RATS, WISTAR; SEROTONIN AGENTS; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS; STEROIDS;

EID: 33746842704     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2006.05.003     Document Type: Article

References (54)

1. Abramowitz J.S., Schwartz S.A., Moore K.M., and Luenzmann K.R. Obsessive-compulsive symptoms in pregnancy and the puerperium: a review of the literature. Anxiety Disord. 17 (2003) 461-478
2. Agrati D., Zuluaga M.J., Uriarte N., Pereira M., Fernández-Guasti A., and Ferreira A. Compulsive-like behavior according to the sex and the reproductive stage of female rat. Behav. Brain. Res. 116 (2005) 313-319
3. Alves S.E., Weiland N.G., Hayashi S., and McEwen B.S. Immunocytochemical localization of nuclear estrogen receptors and progestin receptors within the rat dorsal raphe nucleus. J. Comp. Neurol. 391 (1998) 322-334
4. Barr L.C., Goodman W.K., Price L.H., Mc Dougle C.J., and Charney D.S. The serotonin hypothesis of obsessive-compulsive disorder: implications of pharmacologic challenge studies. J. Clin. Psychiatry 53 (1992) 17-28
5. Bethea C.L., Lu N.Z., Gundlah C., and Streicher J.M. Diverse actions of ovarian steroids in the serotonin neural system. Front. Neuroendocrinol. 23 (2002) 41-100
6. Bethea C.L., Mirkes S.J., Su A., and Michelson D. Effects of oral estrogen, raloxifene and arzoxifene on gene expression in serotonin neurons of macaques. Psychoneuroendocrinology 27 (2002) 431-445
7. Charney D.S., Goodman W.K., Price C.H., Woods S.W., Rasmussen S.A., and Heninger G.R. Serotonin function in obsessive-compulsive disorder: a comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. Arch. Gen. Psychiatry 65 (1988) 177-185
8. Concas A., Mostallino M.C., Porcu P., Follesa P., Barbaccia M.L., Trabucchi M., Purdy R.H., Grisenti P., and Biggio G. Role of brain allopregnanolone in the plasticity of g-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc. Natl. Acad. Sci. USA. 95 (1998) 13284-13289
9. Denys D., Zohar J., and Westenberg H.G. The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. J. Clin. Psychiatry 65 (2004) 11-17
10. De Vry J., Schreiber R., Melon C., Dalmus M., and Jentzsch K.R. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. Eur. Neuropsychopharmacol. 14 (2004) 487-495
11. Di Paolo T., Levesque D., and Daigle M. A physiological dose of progesterone affects rat striatum biogenic amine metabolism. Eur. J. Pharmacol. 125 (1986) 11-16
12. Einat H., and Szechtman H. Perseveration without hyperlocomotion in a spontaneous alternation task in rats sensitized to the dopamine agonist quinpirole. Physiol. Behav. 57 (1995) 55-59
13. Ellen P., and Deloache J. Hippocampal lesion and spontaneous alternation in the rat. Physiol. Behav. 3 (1968) 857-860
14. Estrada-Camarena E., Fernández-Guasti A., and Lopez-Rubalcava C. Antidepressant-like effect of different estrogenic compounds in the forced swimming test. Neuropsychopharmacology 28 (2003) 830-838
15. Estrada-Camarena E., Fernández-Guasti A., and Lopez-Rubalcava C. Participation of the 5-HT1A receptor in the antidepressant-like effect of estrogens in the forced swimming test. Neuropsychopharmacology 31 (2006) 247-255
16. Fernández-Guasti A., Ulloa R.E., and Nicolini H. Age differences in the sensitivity to clomipramine in an animal model of obsessive-compulsive disorder. Psychopharmacology 166 (2003) 195-201
17. Fernández-Guasti A., Swaab D., and Rodriguez-Manzo G. Sexual behavior reduces hypothalamic androgen receptor immunoreactivity. Psychoneuroendocrinology 28 (2003) 501-512
18. Frankfurt M., McKittrick C.R., Mendelson S.D., and McEwen B.S. Effect of 5,7-dihydroxytryptamine, ovariectomy and gonadal steroids on serotonin receptor binding in rat brain. Neuroendocrinology 59 (1994) 245-250
19. Gaggi R., Dall'Olio R., and Roncada P. Effect of the selective 5-HT receptor agonists 8-OHDPAT and DOI on behavior and brain biogenic amines of rats. Gen. Pharmacol. 28 (1997) 583-587
20. Gervais J., and Rouillard C. Dorsal raphe stimulation differentially modulates dopaminergic neurons in the ventral tegmental area and substantia nigra. Synapse 35 (2000) 281-291
21. Greco B., Allegretto E.A., Tetel M.J., and Blaustein J.D. Coexpression of ER beta with ER alpha and progestin receptor proteins in the female rat forebrain: effects of estradiol treatment. Endocrinology 142 (2001) 5172-5181
22. Guerra-Araiza C., Villamar-Cruz O., Gonzalez-Arenas A., Chavira R., and Camacho-Arroyo I. Changes in progesterone receptor isoforms content in the rat brain during the oestrous cycle and after oestradiol and progesterone treatments. J. Neuroendocrinol. 15 (2003) 984-990
23. Gundlah C., Simon L.D., and Auerbach S.B. Differences in hypothalamic serotonin between estrous phases and gender: an in vivo microdialysis study. Brain. Res. 785 (1998) 91-96
24. Hervas I., and Artigas F. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors. Eur. J. Pharmacol. 358 (1998) 9-18
25. Isgor C., Huang G.C., Akil H., and Watson S.J. Correlation of estrogen beta-receptor messenger RNA with endogenous levels of plasma estradiol and progesterone in the female rat hypothalamus, the bed nucleus of stria terminalis and the medial amygdala. Brain Res. Mol. Brain Res. 106 (2002) 30-41
26. Kornstein S.G., Schatzberg A.F., Thase M.E., Yonkers K.A., McCullough J.P., Keitner G.I., Gelenberg A.J., Davis S.M., Harrison W.M., and Keller M.B. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am. J. Psychiatry 157 (2000) 1445-1452
27. Lehmann O., Jeltsch H., Lehnardt O., Pain L., Lazarus C., and Cassel J.C. Combined lesions of cholinergic and serotonergic neurons in the rat brain using 192 IgG-saporin and 5,7-dihydroxytryptamine: neurochemical and behavioural characterization. Eur. J. Neurosci. 12 (2002) 67-79
28. Lehmann O., Jeltsch H., Lehnardt O., Pain L., Lazarus C., and Cassel J.C. Combined lesions of cholinergic and serotonergic neurons in the rat brain using 192 IgG-saporin and 5,7-dihydroxytryptamine: neurochemical and behavioural characterization. Erratum in: Eur J. Neurosci. 15 (2002) 221
29. Martenyi F., Dossenbach M., Mraz K., and Metcalfe S. Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile. Eur. Neuropsychopharmacol. 11 (2001) 227-232
30. Maswood S., Stewart G., and Uphouse L. Gender and estrous cycle effects of the 5-HT1A agonist, 8-OH-DPAT, on hypothalamic serotonin. Pharmacol. Biochem. Behav. 51 (1995) 807-813
31. Mendelson S.D., McKittrick C.R., and McEwen B.S. Autoradiographic analyses of the effects of estradiol benzoate on [3H]paroxetine binding in the cerebral cortex and dorsal hippocampus of gonadectomized male and female rats. Brain Res. 601 (1993) 299-302
32. Mermelstein P.G., and Becker J.B. Increased extracellular dopamine in the nucleus accumbens and striatum of the female rat during paced copulatory behavior. Behav. Neurosci. 109 (1995) 354-365
33. Micallef J., and Blin O. Neurobiology and clinical pharmacology of obsessive-compulsive disorder. Clin. Neuropharmacol. 24 (2001) 191-207
34. Mize A.L., Poisner A.M., and Alper R.H. Estrogens act in rat hippocampus and frontal cortex to produce rapid, receptor-mediated decreases in serotonin 5-HT(1A) receptor function. Neuroendocrinology 73 (2001) 166-174
35. Montes G.S., and Luque E.H. Effects of ovarian steroids on vaginal smears in the rat. Acta Anat. 133 (1983) 192-199
36. Morissette M., Levesque D., Belanger A., and Di Paolo T. A physiological dose of estradiol with progesterone affects striatum biogenic amines. Can. J. Physiol. Pharmacol. 68 (1990) 1520-1526
37. Mundo E., Bareggi S.R., Pirola R., and Bellodi L. Effects of acute intravenous clomipramine and antiobsessional response to proserotonergic drugs: is gender a predictive variable?. Biol. Psychiatr. 45 (1999) 290-294
38. Page M.E., Detke M.J., Dalvi A., Kirby L.G., and Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology 147 (1999) 162-167
39. Pecins-Thompson M., Brown N.A., and Bethea C.L. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Res. Mol. Brain Res. 53 (1998) 120-129
40. Raskin A. Age-sex differences in response to antidepressant drugs. J. Nerv. Ment. Dis. 159 (1974) 120-130
41. Robinson G.E., and Stewart D.E. Postpartum psychiatric disorders. Can. Med. Assoc. J. 134 (1986) 31-37
42. Rubinow D.R., Schmidt P.J., and Roca C.A. Estrogen-serotonin interaction: Implications for affective regulation. Biol. Psychiatry 44 (1998) 839-850
43. Savoy-Moore R., Schwartz N.A., Duncan J.A., and Marshall J.C. Pituitary gonadotropin-releasing hormone receptors during the rat estrous cycle. Science 209 (1980) 924-944
44. Shiloh R., Nutt D., and Weizman A. Atlas of Psychiatric Pharmacotherapy (2000), Martin Dunitz, London, UK
45. Siegel S. Nonparametric Statistic for the Behavioral Sciences (1956), McGraw Hill, New York
46. Sodersten P., Eneroth P., and Hansen S. Induction of sexual receptivity in ovariectomized rats by pulse administration of oestradiol-17 beta. J. Endocrinol. 89 (1981) 55-62
47. Tao R., Ma Z., and Auerbach S.B. Differential regulation of 5-hydroxytryptamine release by GABAA and GABAB receptors in midbrain raphe nuclei and forebrain of rats. Br. J. Pharmacol. 119 (1996) 1375-1384
48. Thomas G.J., and Brito G.N.O. Recovery of delayed alternation in rats after lesions in medial frontal cortex and septum. J. Comp. Physiol. Psychol. 96 (1980) 808-818
49. Ulloa R.E., Nicolini H., and Fernández-Guasti A. Sex differences on spontaneous alternation in prepuberal rats: implications for an animal model of obsessive-compulsive disorder. Progr. Neuropsychopharmacol. Biol. Psychiatr. 28 (2004) 687-692
50. Viau V., and Meaney M.J. α1 adrenoreceptors mediate the stimulatory effects of oestrogen on stress-related hypothalamic-pituitary-adrenal activity in the female rat. J. Neuroendocrinol. 16 (2004) 72-78
51. Weis B.J., and Means L.W. A comparison of the effect of medial frontal, dorsal medial thalamic, and combination lesions on discrimination and spontaneous alternation in the rat. Physiol. Psychol. 8 (1980) 325-329
52. Yadin E., Friedman E., and Bridger W.H. Spontaneous alternation behavior: an animal model for obsessive-compulsive disorder?. Pharmacol. Biochem. Behav. 40 (1991) 311-315
53. Zohar J., Insel T.R., Zohar-Kadouch R.C., Hill J.L., and Murphy D.L. Serotoninergic responsivity in obsessive-compulsive disorder. Arch. Gen. Psychiatr. 45 (1988) 167-172
54. Zohar J., Gross-Isseroff R., Hermesh H., and Weizman A. Is there sexual dimorphism in obsessive-compulsive disorder?. Neurosci. Biobehav. Res. 23 (1999) 845-849